Dimensional Fund Advisors LP Editas Medicine, Inc. Transaction History

Dimensional Fund Advisors LP

  • $391 Billion
  • Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,608,477 shares of EDIT stock, worth $2.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,608,477
Previous 2,159,512 25.52%
Holding current value
$2.77 Million
Previous $2.74 Million 31.98%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$1.14 - $3.2 $628,179 - $1.76 Million
-551,035 Reduced 25.52%
1,608,477 $1.87 Million
Q4 2024

Feb 13, 2025
SELL
$1.2 - $3.76 $129,117 - $404,568
-107,598 Reduced 4.75%
2,159,512 $2.74 Million
Q3 2024

Nov 07, 2024
SELL
$3.39 - $5.96 $264,230 - $464,546
-77,944 Reduced 3.32%
2,267,110 $7.73 Million
Q2 2024

Aug 09, 2024
SELL
$4.67 - $7.28 $1.23 Million - $1.91 Million
-262,711 Reduced 10.07%
2,345,054 $11 Million
Q1 2024

May 10, 2024
BUY
$7.03 - $11.07 $1.51 Million - $2.38 Million
215,369 Added 9.0%
2,607,765 $19.3 Million
Q4 2023

Feb 07, 2024
BUY
$6.25 - $11.11 $4.31 Million - $7.67 Million
690,366 Added 40.56%
2,392,396 $24.2 Million
Q3 2023

Nov 09, 2023
SELL
$6.92 - $9.31 $451,177 - $607,002
-65,199 Reduced 3.69%
1,702,030 $13.3 Million
Q2 2023

Aug 09, 2023
BUY
$6.36 - $11.47 $988,827 - $1.78 Million
155,476 Added 9.65%
1,767,229 $14.5 Million
Q1 2023

May 12, 2023
SELL
$7.03 - $11.53 $268,946 - $441,103
-38,257 Reduced 2.32%
1,611,753 $11.7 Million
Q4 2022

Feb 09, 2023
BUY
$8.32 - $13.21 $8.27 Million - $13.1 Million
993,508 Added 151.33%
1,650,010 $14.6 Million
Q3 2022

Nov 10, 2022
SELL
$12.16 - $19.42 $468,840 - $748,757
-38,556 Reduced 5.55%
656,502 $8.04 Million
Q2 2022

Aug 12, 2022
SELL
$9.99 - $21.35 $1.72 Million - $3.67 Million
-171,857 Reduced 19.82%
695,058 $8.22 Million
Q1 2022

May 13, 2022
SELL
$14.08 - $27.63 $302,142 - $592,912
-21,459 Reduced 2.42%
866,915 $16.5 Million
Q4 2021

Feb 09, 2022
BUY
$26.55 - $40.57 $4.74 Million - $7.25 Million
178,608 Added 25.16%
888,374 $23.6 Million
Q3 2021

Nov 12, 2021
BUY
$39.27 - $72.94 $3.17 Million - $5.89 Million
80,735 Added 12.83%
709,766 $29.2 Million
Q2 2021

Aug 12, 2021
BUY
$31.29 - $56.64 $11.3 Million - $20.4 Million
360,003 Added 133.82%
629,031 $35.6 Million
Q1 2021

May 14, 2021
BUY
$39.71 - $90.58 $6.29 Million - $14.4 Million
158,510 Added 143.42%
269,028 $11.3 Million
Q4 2020

Feb 25, 2021
BUY
$27.07 - $84.35 $2.99 Million - $9.32 Million
110,518 New
110,518 $7.75 Million

Others Institutions Holding EDIT

# of Institutions
218
Shares Held
48.4M
Call Options Held
436K
Put Options Held
324K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $118M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email